Skip to content
Trial Eligibility
Menu

Obesity Clinical Trials near Austin, TX

23 studies for Obesity are recruiting at 25 sites within 50 miles of Austin, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Obesity trials in the US or all trials near Austin.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Obesity studies enrolling near Austin

Showing 23 studies, nearest first.
  1. Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

    NCT07037433

    • Phase 3
    • Ages 45 to 99 years
    • Sex: All

    Nearest sites: Austin Heart (Austin, TX); Velocity Clinical Research - Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

    NCT07752979

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Elligo Clinical Research Center /ID# 282166 (Austin, TX); Texas Diabetes and Endocrinology /ID# 282291 (Round Rock, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

    NCT06143956

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: IMA Clinical Research Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. Semaglutide for Post-Smoking Cessation Weight Management

    NCT06173778

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: The University of Texas at Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Mothers and CareGivers Investing in Children Study 2.0

    NCT06719102

    • Interventional
    • Ages 0 to 90 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Dell Pediatric Research Institute (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    NCT07037459

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Austin Heart (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

    NCT07282600

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: IMA Clinical Research Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

    NCT07369011

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: FutureSearch Trials of Neurology (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

    NCT07480109

    • Interventional
    • Ages 30 to 60 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest site: Dell Pediatric Research Center (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

    NCT07575399

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Pinnacle Clinical Research Georgetown (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

    NCT07589608

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: IMA Clinical Research Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

    NCT07607587

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Elligo Clin Res Centre (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

    NCT07652047

    • Phase 1
    • Ages 18 to 55 years
    • Sex: Female

    Nearest site: Corxel Investigational Site (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

    NCT07654361

    • Phase 3
    • Ages 18 to 79 years
    • Sex: All

    Nearest site: ACCOMPLISH-1 Research Site (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

    NCT07654374

    • Phase 3
    • Ages 18 to 79 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: ACCOMPLISH-2 Research Site (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

    NCT07668414

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Diabetes & Endocrinology (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

    NCT07684144

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Elligo Clinical Research Center (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

    NCT07684235

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Elligo Clinical Research Center (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

    NCT07743450

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AURORA-2 Clinical Site (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

    NCT07743463

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AURORA-1 Clinical Site (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

    NCT07794579

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: IMA Clinical Research Austin (Austin, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

    NCT06857942

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: Austin Institute for Clinical Research (Pflugerville, TX)

    Distance to nearest recruiting site
    ~14 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

    NCT06897475

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Texas Diabetes & Endocrinology, P.A. (Round Rock, TX)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Obesity clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.